Brasada Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.43M | Buy |
90,117
+252
| +0.3% | +$26.4K | 1.6% | 17 |
|
|
2025
Q1 | $8.23M | Sell |
89,865
-5,412
| -6% | -$495K | 1.64% | 19 |
|
|
2024
Q4 | $8.96M | Sell |
95,277
-786
| -0.8% | -$73.9K | 1.57% | 18 |
|
|
2024
Q3 | $8.11M | Sell |
96,063
-4,714
| -5% | -$398K | 1.42% | 23 |
|
|
2024
Q2 | $7.75M | Sell |
100,777
-1,208
| -1% | -$92.9K | 1.35% | 23 |
|
|
2024
Q1 | $6.98M | Buy |
101,985
+722
| +0.7% | +$49.5K | 1.23% | 22 |
|
|
2023
Q4 | $5.85M | Buy |
101,263
+10,986
| +12% | +$635K | 1.13% | 25 |
|
|
2023
Q3 | $4.74M | Sell |
90,277
-1,365
| -1% | -$71.7K | 1.11% | 26 |
|
|
2023
Q2 | $4.96M | Buy |
91,642
+71,642
| +358% | +$3.88M | 1.07% | 28 |
|
|
2023
Q1 | $1M | Buy |
+20,000
| New | +$1M | 0.22% | 82 |
|
|
2020
Q4 | – | Sell |
-12,000
| Closed | -$459K | – | 143 |
|
|
2020
Q3 | $459K | Buy |
+12,000
| New | +$459K | 0.12% | 108 |
|
|
2020
Q1 | – | Sell |
-20,000
| Closed | -$904K | – | 120 |
|
|
2019
Q4 | $904K | Sell |
20,000
-2,000
| -9% | -$90.4K | 0.22% | 80 |
|
|
2019
Q3 | $895K | Sell |
22,000
-500
| -2% | -$20.3K | 0.24% | 79 |
|
|
2019
Q2 | $967K | Buy |
22,500
+7,500
| +50% | +$322K | 0.26% | 78 |
|
|
2019
Q1 | $576K | Buy |
15,000
+2,500
| +20% | +$96K | 0.17% | 95 |
|
|
2018
Q4 | $442K | Buy |
+12,500
| New | +$442K | 0.15% | 112 |
|
|
2018
Q3 | – | Sell |
-4,000
| Closed | -$131K | – | 377 |
|
|
2018
Q2 | $131K | Buy |
+4,000
| New | +$131K | 0.04% | 178 |
|
|
2018
Q1 | – | Sell |
-20,000
| Closed | -$496K | – | 256 |
|
|
2017
Q4 | $496K | Buy |
+20,000
| New | +$496K | 0.17% | 98 |
|